Categories
twitter-es

Most pregnant women 🤰🏾 surveyed expressed a strong desire to breastfeed exclusively. However, a sustained flow of misleading marketing messages

admin - 11:31, 10 de marzo de 2022595

Most pregnant women 🤰🏾 surveyed expressed a strong desire to breastfeed exclusively.

However, a sustained flow of misleading marketing messages reinforces myths about #breastfeeding & breast milk, undermining women’s confidence in their ability to breastfeed successfully. https://t.co/4EazCEPVqM

 
Categories
rss-es

Baxter recalls SIGMA Spectrum Infusion Pumps with Master Drug Library (Version 8) and Spectrum IQ Infusion Systems with Dose IQ Safety Software (Version 9) due to the risk of not alarming for repeated upstream occlusion events

Murilo Freitas - 05:00, 10 de marzo de 2022488
There is a risk of the pumps not delivering medication at the programmed rate displayed on the screen, and in some cases may not alarm for upstream occlusions.

http://www.fda.gov/medical-devices/medical-device-recalls/baxter-recalls-sigma-spectrum-infusion-pumps-master-drug-library-version-8-and-spectrum-iq-infusion

 
Categories
rss rss-es rss-pt

ACON Laboratories Issues a Recall of Non-EUA Authorized “Flowflex™ SARS-CoV-2 Antigen Rapid Test (Self-Testing)” Tests From the U.S. Market

Murilo Freitas - 05:00, 10 de marzo de 2022687
ACON Laboratories, Inc. (“ACON Laboratories”), the legal manufacturer of the “Flowflex™ COVID-19 Antigen Home Test” (FDA Emergency Use Authorization EUA210494), has identified the U.S. distribution of unauthorized, adulterated and misbranded counterfeit product having the trade name “Flowflex SARS-C

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/acon-laboratories-issues-recall-non-eua-authorized-flowflextm-sars-cov-2-antigen-rapid-test-self

 
PRAIS 2.0